These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7144293)

  • 1. [Acute myeloproliferative syndrome after alkylating agent treatment in a case of multiple myeloma].
    Gardella S; Cervantes F; Bladé J; Brugués R; Rozman C
    Med Clin (Barc); 1982 Sep 1-15; 79(4):185-8. PubMed ID: 7144293
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dysmyelopoietic syndrome 7 years after melphalan treatment of multiple myeloma. Clinical case].
    Scolozzi R; Boccafogli A
    Minerva Med; 1983 Jul; 74(28-29):1783-5. PubMed ID: 6866310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leukemia in tumor patients receiving chemotherapy].
    Fopp M; Senn HJ
    Dtsch Med Wochenschr; 1985 Sep; 110(38):1439-41. PubMed ID: 3861311
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasmocytoma, alkylating agents, and acute myeloid leukemia (author's transl)].
    Schmalzl F; Keiser G; Kresbach E; Fritz H; Asamer H; Braunsteiner H
    Dtsch Med Wochenschr; 1975 Sep; 100(39):1961-7. PubMed ID: 1057506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute leukaemia after alkylating-agent therapy of ovarian cancer.
    Bell DR; Woods RL; Levi JA
    Med J Aust; 1982 Sep; 2(5):243-4. PubMed ID: 7132879
    [No Abstract]   [Full Text] [Related]  

  • 6. Alkylating agents as leukemogens in multiple myeloma.
    Karchmer RK; Amare M; Larsen WE; Mallouk AG; Caldwell GG
    Cancer; 1974 Apr; 33(4):1103-7. PubMed ID: 4522494
    [No Abstract]   [Full Text] [Related]  

  • 7. Kaposi's sarcoma after long-term alkylating agent therapy for multiple myeloma.
    Kapadia SB; Krause JR
    South Med J; 1977 Aug; 70(8):1011-3. PubMed ID: 887963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myelomonoblastic leukemia in a patient with multiple myeloma.
    Colović M; Jovanović V; Ristić M
    Acta Med Iugosl; 1989; 43(1):77-82. PubMed ID: 2711863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukaemia and cytotoxic drugs.
    Lancet; 1971 Jan; 1(7689):70-1. PubMed ID: 4099223
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of acute leukosis in multiple myeloma after prolonged treatment with melphalan].
    Scheinberg MA; Bezerra JB; Silveira LA; Ferreira HC; Maspes V
    AMB Rev Assoc Med Bras; 1978 Oct; 24(10):356-7. PubMed ID: 311053
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute granulous leukemia in multiple myeloma. Apropos of 5 cases].
    Krulik M; Grolleau JY; Audebert AA; Mougeot-Martin M; Harousseau JL; Hervouet D; Debray J
    Sem Hop; 1977 Dec; 53(42):2425-35. PubMed ID: 203043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of acute erythroleukemia in B-cell immunoproliferative disorders after prolonged therapy with alkylating drugs.
    Cardamone JM; Kimmerle RI; Marshall EY
    Am J Med; 1974 Nov; 57(5):836-42. PubMed ID: 4216270
    [No Abstract]   [Full Text] [Related]  

  • 13. [Case of IgG-K myeloma successfully treated with melphalan but terminating in acute myelogenous leukemia 2 years and 8 months later].
    Saitoh A; Tsushima T; Narita K; Fujiwara S; Kawamura S; Chiba Y; Yoshida Y
    Rinsho Ketsueki; 1982 Jun; 23(6):862-9. PubMed ID: 6960198
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukemia after treatment of ovarian cancer with alkylating agents.
    Parker LM
    N Engl J Med; 1983 Jun; 308(23):1422. PubMed ID: 6843637
    [No Abstract]   [Full Text] [Related]  

  • 15. [Granulocytic sarcoma in acute non-lymphoblastic leukemia as the terminal phase of multiple myeloma under prolonged treatment with alkylating agents].
    Bernardeschi P; Urbano U
    Haematologica; 1983; 68(5):684-8. PubMed ID: 6416948
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myeloma, melphalan and acute myelo-monocytic leukemia. Apropos of a case].
    Cywiner-Golenzer C; Adotti F; Marsan C; Quillard A; Henon P; Grimaldi A; Dryll A
    Sem Hop; 1974 Jan; 50(3):207-11. PubMed ID: 4367926
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic myelomonocytic leukemia following prolonged alkylating agent therapy for multiple myeloma.
    Natazuka T; Yamaguchi T; Murayama T; Fukase M; Matsui T; Isobe T; Chihara K
    Int J Hematol; 1994 Dec; 60(4):263-5. PubMed ID: 7894029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myeloma together with acute myeloblastic leukaemia in an untreated patient (author's transl)].
    Vallantin X; Tobelem G; Daniel MT; Flandrin G; Brouet JC; Bernard J
    Nouv Presse Med; 1980 Sep; 9(35):2559-60. PubMed ID: 6933406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythroleukemia following melphalan therapy for multiple myeloma.
    Fishman SA; Ritz ND
    N Y State J Med; 1975 Nov; 75(13):2402-4. PubMed ID: 1059018
    [No Abstract]   [Full Text] [Related]  

  • 20. Deletion of 5q31 and 7q31 in patients with stable melphalan treated multiple myeloma.
    Amiel A; Yukla M; Yogev S; Manor Y; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):84-7. PubMed ID: 15193449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.